Brugada syndrome (BrS) is an arrhythmogenic disease associated with an increased risk of
ventricular fibrillation (VF) and sudden cardiac death (SCD). To date, the standard therapy …

Three decades have passed since the Brugada syndrome (BrS) clinical entity was
introduced in the early 1990s. 1 During the first 2 decades, treatment of patients with BrS …

Abstract Background Brugada Syndrome (BrS) is a life-threatening cardiac arrhythmia
disorder associated with an increased risk ventricular arrhythmias (VAs) and sudden cardiac …

Background: Catheter ablation (CA) is effective for recurrent episodes of ventricular
fibrillation (VF) in Brugada syndrome (BrS). VF development in BrS is associated with …

Abstract Background Patients with Brugada syndrome (BrS) may experience recurrent
ventricular arrhythmias (VAs). Catheter ablation is becoming an emerging paradigm for …

Background: Treatment options for high-risk Brugada syndrome (BrS) with recurrent
ventricular fibrillation (VF) are limited. Catheter ablation is increasingly performed but a large …

Implantable cardioverter defibrillator implantation in Brugada syndrome Arrhythmic SCD is a
significant cause of mortality, 5–15% of people with SCD have no structural abnormalities …

Clinical manifestation of Brugada syndrome (BrS) mainly results from polymorphic
ventricular arrhythmias and includes sudden cardiac arrest (SCA). The Brugada sign …

Background Ablation approaches have been described for the management of symptomatic
ventricular arrhythmias in patients with Brugada syndrome, but this treatment is still …

Brugada syndrome is a congenital electrical disorder characterised by the appearance of
distinctive QRST-T patterns in the right precordial leads and an increased risk of sudden …